- Home
- PKE vs KRRO Comparison
PKE vs KRRO Comparison
Compare PKE & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKE
- KRRO
- Stock Information
- Founded
- PKE 1954
- KRRO 2014
- Country
- PKE United States
- KRRO United States
- Employees
- PKE N/A
- KRRO N/A
- Industry
- PKE Military/Government/Technical
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- PKE Industrials
- KRRO Health Care
- Exchange
- PKE Nasdaq
- KRRO Nasdaq
- Market Cap
- PKE 378.7M
- KRRO 358.3M
- IPO Year
- PKE N/A
- KRRO 2019
- Fundamental
- Price
- PKE $19.92
- KRRO $48.57
- Analyst Decision
- PKE
- KRRO Strong Buy
- Analyst Count
- PKE 0
- KRRO 7
- Target Price
- PKE N/A
- KRRO $96.71
- AVG Volume (30 Days)
- PKE 131.6K
- KRRO 233.8K
- Earning Date
- PKE 10-09-2025
- KRRO 11-11-2025
- Dividend Yield
- PKE 2.51%
- KRRO N/A
- EPS Growth
- PKE 4.18
- KRRO N/A
- EPS
- PKE 0.34
- KRRO N/A
- Revenue
- PKE $63,456,000.00
- KRRO $6,281,000.00
- Revenue This Year
- PKE N/A
- KRRO $116.91
- Revenue Next Year
- PKE N/A
- KRRO N/A
- P/E Ratio
- PKE $58.50
- KRRO N/A
- Revenue Growth
- PKE 16.60
- KRRO N/A
- 52 Week Low
- PKE $11.97
- KRRO $10.29
- 52 Week High
- PKE $21.01
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- PKE 59.87
- KRRO 72.86
- Support Level
- PKE $19.54
- KRRO $43.41
- Resistance Level
- PKE $20.75
- KRRO $49.01
- Average True Range (ATR)
- PKE 0.78
- KRRO 4.42
- MACD
- PKE -0.01
- KRRO 0.46
- Stochastic Oscillator
- PKE 54.97
- KRRO 93.46
About PKE Park Aerospace Corp.
Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.